Catalyst Wire Dossier Catalyst Wire Dossier

MMRV vaccine (investigational, combined measles-mumps-rubella-varicella vaccine)

measles-mumps-rubella-varicella vaccine, investigational (combined) · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMRV vaccine (investigational, combined measles-mumps-rubella-varicella vaccine), covering 2026-02-12 to 2026-02-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age [Phase 3]

See pricing